Gamida Cell (GMDA) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free GMDA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media Gamida Cell Short Interest DataCurrent Short Volume10,960,000 sharesPrevious Short Volume9,980,000 sharesChange Vs. Previous Month+9.82%Dollar Volume Sold Short$3.50 millionShort Interest Ratio / Days to Cover3.6Last Record DateMarch 15, 2024Outstanding Shares154,051,000 sharesPercentage of Shares Shorted7.11%Today's Trading Volume23,036,800 sharesAverage Trading Volume9,201,723 sharesToday's Volume Vs. Average250% Short Selling Gamida Cell ? Sign up to receive the latest short interest report for Gamida Cell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGMDA Short Interest Over TimeGMDA Days to Cover Over TimeGMDA Percentage of Float Shorted Over Time Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Gamida Cell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202410,960,000 shares $3.50 million +9.8%N/A3.6 $0.32 2/29/20249,980,000 shares $3.59 million +0.2%N/A3.4 $0.36 2/15/20249,960,000 shares $3.93 million +12.4%N/A3.1 $0.40 1/31/20248,860,000 shares $3.41 million +11.7%N/A2.4 $0.39 1/15/20247,930,000 shares $2.27 million +19.1%N/A2.7 $0.29 12/31/20236,660,000 shares $2.75 million -5.4%N/A2.7 $0.41 Get the Latest News and Ratings for GMDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter. 12/15/20237,040,000 shares $2.22 million -16.3%N/A3.5 $0.32 11/30/20238,410,000 shares $2.61 million +1.8%N/A4.5 $0.31 11/15/20238,260,000 shares $3.01 million +12.4%N/A5.1 $0.37 10/31/20237,350,000 shares $5.40 million +10.7%N/A7.1 $0.74 10/15/20236,640,000 shares $5.38 million +6.8%N/A5.8 $0.81 9/30/20236,220,000 shares $6.41 million +12.1%N/A4.9 $1.03 9/15/20235,550,000 shares $6.33 million +10.6%N/A3.8 $1.14 8/31/20235,020,000 shares $5.92 million +10.1%N/A3.2 $1.18 8/15/20234,560,000 shares $5.70 million +14.0%N/A2.5 $1.25 7/31/20234,000,000 shares $5.72 million +22.7%N/A1.8 $1.43 7/15/20233,260,000 shares $4.92 million -11.4%N/A1.1 $1.51 6/30/20233,680,000 shares $7.10 million -13.8%N/A0.7 $1.93 6/15/20234,270,000 shares $8.37 million +34.3%N/A0.8 $1.96 5/31/20233,180,000 shares $6.68 million -35.9%N/A0.6 $2.10 5/15/20234,960,000 shares $10.12 million -39.5%N/A1 $2.04 4/30/20238,200,000 shares $13.12 million +13.7%N/A1.9 $1.60 4/15/20237,210,000 shares $5.82 million +11.1%N/A1.9 $0.81 3/31/20236,490,000 shares $5.26 million +26.3%11.3%6 $0.81 3/15/20235,140,000 shares $7.86 million -7.7%9.8%8.4 $1.53 2/28/20235,570,000 shares $8.19 million -2.6%9.8%10.1 $1.47 2/15/20235,720,000 shares $8.12 million +8.8%10.1%11 $1.42 1/31/20235,260,000 shares $8.42 million +14.6%N/A10 $1.60 1/15/20234,590,000 shares $7.30 million +15.3%N/A8.8 $1.59 12/30/20223,980,000 shares $5.13 million -0.5%N/A7.8 $1.29 12/15/20224,000,000 shares $5.24 million -2.2%N/A7.2 $1.31 11/30/20224,090,000 shares $6.54 million +15.2%N/A7.9 $1.60 11/15/20223,550,000 shares $6.75 million +4.1%N/A6.7 $1.90 10/31/20223,410,000 shares $6.10 million +5.9%6.1%5.4 $1.79 10/15/20223,220,000 shares $5.57 million +40.0%5.8%4.8 $1.73 9/30/20222,300,000 shares $3.66 million -10.5%4.1%3.5 $1.59 9/15/20222,570,000 shares $6.63 million -5.2%5.7%4.5 $2.58 8/31/20222,710,000 shares $7.18 million -9.4%6.0%4.8 $2.65 8/15/20222,990,000 shares $9.66 million +15.4%6.6%5.6 $3.23 7/31/20222,590,000 shares $4.33 million -4.8%5.7%6.8 $1.67Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide GMDA Short Interest - Frequently Asked Questions What is Gamida Cell's current short interest? Short interest is the volume of Gamida Cell shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 10,960,000 shares of GMDA short. Learn More on Gamida Cell's current short interest. What is a good short interest ratio for Gamida Cell? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMDA shares currently have a short interest ratio of 4.0. Learn More on Gamida Cell's short interest ratio. Is Gamida Cell's short interest increasing or decreasing? Gamida Cell saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 10,960,000 shares, an increase of 9.8% from the previous total of 9,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Gamida Cell's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Gamida Cell: Fresh Tracks Therapeutics, Inc. (0.17%), TRACON Pharmaceuticals, Inc. (1.16%), Titan Pharmaceuticals, Inc. (1.72%), Creative Medical Technology Holdings, Inc. (1.76%), Finch Therapeutics Group, Inc. (1.96%), Palisade Bio, Inc. (4.12%), Avalon GloboCare Corp. (2.84%), Windtree Therapeutics, Inc. (0.51%), Organovo Holdings, Inc. (1.49%), BioCardia, Inc. (1.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Gamida Cell stock? Short selling GMDA is an investing strategy that aims to generate trading profit from Gamida Cell as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gamida Cell? A short squeeze for Gamida Cell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GMDA, which in turn drives the price of the stock up even further. How often is Gamida Cell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMDA, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Fresh Tracks Therapeutics Short Interest TRACON Pharmaceuticals Short Interest Titan Pharmaceuticals Short Interest Creative Medical Technology Short Interest Finch Therapeutics Group Short Interest Palisade Bio Short Interest Avalon GloboCare Short Interest Windtree Therapeutics Short Interest Organovo Short Interest BioCardia Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GMDA) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders